Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
暂无分享,去创建一个
[1] D. Gospodarowicz,et al. Brain-derived fibroblast growth factor: a study of its inactivation. , 1983, Life Science.
[2] D. Gospodarowicz,et al. Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.
[3] D. Gospodarowicz,et al. Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.
[4] D. Gospodarowicz,et al. Identification of the fibroblast growth factor receptor in human vascular endothelial cells , 1988, Journal of cellular physiology.
[5] T. Maciag,et al. The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.
[6] Fibroblast growth factors. , 1989, British medical bulletin.
[7] J. Folkman,et al. The fate of intravenously administered bFGF and the effect of heparin. , 1989, Growth factors.
[8] B. Matthews,et al. Three-dimensional structure of human basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] R Langer,et al. Controlled and modulated release of basic fibroblast growth factor. , 1991, Biomaterials.
[10] J. Vacanti,et al. Tissue engineering : Frontiers in biotechnology , 1993 .
[11] J. Vacanti,et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. , 1993, The Journal of urology.
[12] E. Edelman,et al. Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Dell’Era,et al. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. , 1994, Biochemical and biophysical research communications.
[14] T. Arakawa,et al. Stoichiometry of heparin binding to basic fibroblast growth factor. , 1994, Archives of biochemistry and biophysics.
[15] Y. Baruch,et al. Basic fibroblast growth factor is hepatotropic for rat liver in regeneration. , 1995, Journal of hepatology.
[16] C. Colton,et al. Implantable biohybrid artificial organs. , 1995, Cell transplantation.
[17] Clark K. Colton,et al. Implantable Biohybrid Artificial Organs , 1995 .
[18] E. Edelman,et al. Cellular Response to Transforming Growth Factor-β1 and Basic Fibroblast Growth Factor Depends on Release Kinetics and Extracellular Matrix Interactions* , 1996, The Journal of Biological Chemistry.
[19] L. Shapiro,et al. Novel alginate sponges for cell culture and transplantation. , 1997, Biomaterials.
[20] Smadar Cohen,et al. Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy , 1997 .
[21] E. Keshet,et al. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.
[22] Y. Ikada,et al. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. , 1999, Journal of biomaterials science. Polymer edition.
[23] Robert Langer,et al. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation , 1999, The Lancet.
[24] Thomas N. Sato,et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.
[25] D. Ecker,et al. Transplantation of islets using microencapsulation: studies in diabetic rodents and dogs , 1999, Journal of Molecular Medicine.
[26] J. Merchuk,et al. Hepatocyte behavior within three-dimensional porous alginate scaffolds. , 2000, Biotechnology and bioengineering.
[27] E. Voronov,et al. Macrophage activation for the production of immunostimulatory cytokines by delivering interleukin 1 via biodegradable microspheres. , 2000, Cytokine.
[28] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[29] M. Tanihara,et al. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. , 2001, Journal of biomedical materials research.
[30] A A Poot,et al. Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.
[31] K. Sugimachi,et al. Angiogenic Gene Therapy for Experimental Critical Limb Ischemia: Acceleration of Limb Loss by Overexpression of Vascular Endothelial Growth Factor 165 but not of Fibroblast Growth Factor-2 , 2002, Circulation research.
[32] Smadar Cohen,et al. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. , 2002, Biotechnology and bioengineering.
[33] Smadar Cohen,et al. Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. , 2002, Biomaterials.
[34] Robert Langer,et al. Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres , 1991, Pharmaceutical Research.